Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Panzani produces dry pasta, semolina, couscous and sauces. It was formerly owned by Ebro Foods and sold to CVC Capital Partners for €550 million (~$625 million) at the end of 2021. The transaction included several brands under the Panzani umbrella. The company generated €470 million turnover in 2020 with approximately 750 employees[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Panzani.